ENXTPA:EXENSAerospace & Defense
How Raised 2026 Guidance Will Impact Exosens Stock Investors
Exosens lifted its full-year 2026 guidance in September 2026, now targeting revenue of €558 million to €570 million, compared with a prior range of €520 million to €540 million. The company cited faster capacity ramp-up and solid demand in defense imaging and nuclear instrumentation.
The upgraded outlook highlights how Exosens is turning expanded manufacturing capacity into higher expected earnings. This suggests that operational execution and uptake of mission-critical imaging across...